Search / Trial NCT06616701

The Impact of Routine Follow-up Contacts After a Pediatric ED Visit for Youth With Suicide Risk

Launched by JOHNS HOPKINS UNIVERSITY · Sep 26, 2024

Trial Information

Current as of October 04, 2024

Recruiting

Keywords

Suicidal Thoughts Suicidal Behaviors Suicidal Risk

Description

The month following an ED discharge is a high-risk period for suicide for patients recovering from a suicide attempt and/or experiencing suicidal ideation, making referrals and follow up critically important. Very few hospital systems, if any, have been able to implement policies and practices that ensure patients at risk for suicide are getting the follow up care they need. Patient navigator interventions have demonstrated success in improving health outcomes across a range of conditions including mental health, and moreover, they have been effective in providing practical support and enco...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients ages 8 to 21 years old;
  • * Who present to the emergency department (ED) and are assessed with suicide risk;
  • * Who are discharged from the Johns Hopkins Hospital (Pediatric inpatient psychiatric unit, Pediatric Day Hospital, or Pediatric ED) with a mental health referral
  • Exclusion Criteria:
  • * Patients who were directly transferred to the inpatient psychiatry unit or the Day Hospital from an outside hospital, bypassing the hospital's ED
  • * Direct admissions, bypassing the hospital's ED

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Baltimore, Maryland, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0